Source:http://linkedlifedata.com/resource/pubmed/id/10198699
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
1999-5-27
|
pubmed:abstractText |
EBV was found in 72.7% of 66 LGM patients aged from 4 to 76 years. EBV occurred in 100% of lymphoid depletion, 81% of mixed-cell variant and in 66.6% of nodular sclerosis. The occurrence of virus-positive cases was significantly higher at the age of under 10 years and over 50 years (100%). In the intermediate group it was 65.4 (p < 0.01). Necrotic changes in the lymph nodes were observed more frequently (p < 0.05) when EBV was present. The virus-positive cases of mixed-cell LGM are characterized by increased number of tumor and plasma cells (p < 0.05). EBV was also in a latent state without signs of lytic replication. The influence of the virus manifested in higher expression of antigens CD30 (p < 0.05) and bcl oncoproteins (p < 0.01) as well as in weak CD79 expression (p < 0.05).
|
pubmed:language |
rus
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0004-1955
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
61
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
15-22
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10198699-Adolescent,
pubmed-meshheading:10198699-Adult,
pubmed-meshheading:10198699-Age Distribution,
pubmed-meshheading:10198699-Aged,
pubmed-meshheading:10198699-Child,
pubmed-meshheading:10198699-Child, Preschool,
pubmed-meshheading:10198699-Female,
pubmed-meshheading:10198699-Herpesvirus 4, Human,
pubmed-meshheading:10198699-Hodgkin Disease,
pubmed-meshheading:10198699-Humans,
pubmed-meshheading:10198699-Immunohistochemistry,
pubmed-meshheading:10198699-In Situ Hybridization,
pubmed-meshheading:10198699-Male,
pubmed-meshheading:10198699-Middle Aged,
pubmed-meshheading:10198699-Necrosis
|
pubmed:articleTitle |
[Role of Epstein-Barr virus in the pathogenesis of lymphogranulomatosis. Immunohistochemical and molecular-biological (hybridization in situ) research].
|
pubmed:affiliation |
N. N. Petrov Research Institute of Oncology, St-Petersburg.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
English Abstract
|